United States · FDA National Drug Code directory

Proctozone-B

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
57237-337_ad7d1357-40a1-47d3-bb30-77aaf1547659
Product NDC
57237-337
Form
SUPPOSITORY
Composition / generic term
Bisacodyl
Labeler
Rising Pharma Holdings, Inc.
Marketing category
OTC MONOGRAPH DRUG
Marketing start / end (source format)
20241201
Source listing expiry
20261231

Source-listed ingredients

  • BISACODYL — 10 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 6 BLISTER PACK in 1 CARTON (57237-337-03) / 5 SUPPOSITORY in 1 BLISTER PACK (57237-337-51) · 57237-337-03
  • 3 BLISTER PACK in 1 CARTON (57237-337-21) / 4 SUPPOSITORY in 1 BLISTER PACK (57237-337-04) · 57237-337-21

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →
Proctozone-B — United States | Molindra Medicines